These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 11846839)
1. TNF-alpha is expressed at sites of parasite and tissue destruction in the spleen of mice acutely infected with Trypanosoma cruzi. Lima ES; Andrade ZA; Andrade SG Int J Exp Pathol; 2001 Dec; 82(6):327-36. PubMed ID: 11846839 [TBL] [Abstract][Full Text] [Related]
2. Importance of TNF-alpha in the course of acute infection with Trypanosoma cruzi: influence of its inhibition by pentoxifylline treatment. Andrade SG; Magalhães Ldos A; Pessina DH Mem Inst Oswaldo Cruz; 2008 Feb; 103(1):21-6. PubMed ID: 18345460 [TBL] [Abstract][Full Text] [Related]
3. In-vivo treatment with benznidazole enhances phagocytosis, parasite destruction and cytokine release by macrophages during infection with a drug-susceptible but not with a derived drug-resistant Trypansoma cruzi population. Murta SM; Ropert C; Alves RO; Gazzinelli RT; Romanha AJ Parasite Immunol; 1999 Oct; 21(10):535-44. PubMed ID: 10610497 [TBL] [Abstract][Full Text] [Related]
4. Trypanosoma cruzi-induced depressive-like behavior is independent of meningoencephalitis but responsive to parasiticide and TNF-targeted therapeutic interventions. Vilar-Pereira G; Silva AA; Pereira IR; Silva RR; Moreira OC; de Almeida LR; de Souza AS; Rocha MS; Lannes-Vieira J Brain Behav Immun; 2012 Oct; 26(7):1136-49. PubMed ID: 22841695 [TBL] [Abstract][Full Text] [Related]
6. Is TNF alpha involved in early susceptibility of Trypanosoma cruzi-infected C3H/He mice? Starobinas N; Russo M; Minoprio P; Hontebeyrie-Joskowicz M Res Immunol; 1991 Feb; 142(2):117-22. PubMed ID: 1907750 [TBL] [Abstract][Full Text] [Related]
7. Priming astrocytes with TNF enhances their susceptibility to Trypanosoma cruzi infection and creates a self-sustaining inflammatory milieu. Silva AA; Silva RR; Gibaldi D; Mariante RM; Dos Santos JB; Pereira IR; Moreira OC; Lannes-Vieira J J Neuroinflammation; 2017 Sep; 14(1):182. PubMed ID: 28877735 [TBL] [Abstract][Full Text] [Related]
8. Involvement of nitric oxide (NO) and TNF-alpha in the oxidative stress associated with anemia in experimental Trypanosoma cruzi infection. Malvezi AD; Cecchini R; de Souza F; Tadokoro CE; Rizzo LV; Pinge-Filho P FEMS Immunol Med Microbiol; 2004 May; 41(1):69-77. PubMed ID: 15094169 [TBL] [Abstract][Full Text] [Related]
9. Participation of cytokines in the necrotic-inflammatory lesions in the heart and skeletal muscles of Calomys callosus infected with Trypanosoma cruzi. Magalhães-Santos IF; Andrade SG Mem Inst Oswaldo Cruz; 2005 Aug; 100(5):555-61. PubMed ID: 16184235 [TBL] [Abstract][Full Text] [Related]
10. Characterization of cytokine production in murine Trypanosoma cruzi infection by in situ immunocytochemistry: lack of association between susceptibility and type 2 cytokine production. Zhang L; Tarleton RL Eur J Immunol; 1996 Jan; 26(1):102-9. PubMed ID: 8566051 [TBL] [Abstract][Full Text] [Related]
11. Impact of benznidazole on infection course in mice experimentally infected with Trypanosoma cruzi I, II, and IV. Gruendling AP; Massago M; Teston AP; Monteiro WM; Kaneshima EN; Araújo SM; Gomes ML; Barbosa Md; Toledo MJ Am J Trop Med Hyg; 2015 Jun; 92(6):1178-89. PubMed ID: 25940197 [TBL] [Abstract][Full Text] [Related]
12. Trypanosoma cruzi: Immunological predictors of benznidazole efficacy during experimental infection. Fernández MC; González Cappa SM; Solana ME Exp Parasitol; 2010 Feb; 124(2):172-80. PubMed ID: 19747482 [TBL] [Abstract][Full Text] [Related]
13. DNA damage and nitric oxide synthesis in experimentally infected Balb/c mice with Trypanosoma cruzi. Ribeiro DA; Calvi SA; Picka MM; Persi E; de Carvalho TB; Caetano PK; Nagoshi LR; Lima CR; Machado JM; Salvadori DM Exp Parasitol; 2007 Jul; 116(3):296-301. PubMed ID: 17286971 [TBL] [Abstract][Full Text] [Related]
14. Concomitant Benznidazole and Suramin Chemotherapy in Mice Infected with a Virulent Strain of Trypanosoma cruzi. Santos EC; Novaes RD; Cupertino MC; Bastos DS; Klein RC; Silva EA; Fietto JL; Talvani A; Bahia MT; Oliveira LL Antimicrob Agents Chemother; 2015 Oct; 59(10):5999-6006. PubMed ID: 26169419 [TBL] [Abstract][Full Text] [Related]
16. Elucidating the impact of low doses of nano-formulated benznidazole in acute experimental Chagas disease. Rial MS; Scalise ML; Arrúa EC; Esteva MI; Salomon CJ; Fichera LE PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006119. PubMed ID: 29267280 [TBL] [Abstract][Full Text] [Related]
17. Release of reactive oxygen species by phagocytic cells in response to live parasites in mice infected with Trypanosoma cruzi. Cardoni RL; Antunez MI; Morales C; Nantes IR Am J Trop Med Hyg; 1997 Mar; 56(3):329-34. PubMed ID: 9129538 [TBL] [Abstract][Full Text] [Related]
19. Effects of dehydroepiandrosterone-sulfate (DHEA-S) and benznidazole treatments during acute infection of two different Trypanosoma cruzi strains. Santos CD; Loria RM; Oliveira LG; Kuehn CC; Toldo MP; Albuquerque S; do Prado JC Immunobiology; 2010 Dec; 215(12):980-6. PubMed ID: 20163889 [TBL] [Abstract][Full Text] [Related]
20. Trypanosoma cruzi: alteration in the lymphoid compartments following interruption of infection by early acute benznidazole therapy in mice. Olivieri BP; de Souza AP; Cotta-de-Almeida V; de Castro SL; Araújo-Jorge T Exp Parasitol; 2006 Nov; 114(3):228-34. PubMed ID: 16620811 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]